Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks Stock plan guidance
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Chemring sees FY operating profit in line with views after 'significant' contract wins
(Sharecast News) - Chemring said on Monday that full-year operating profit was set to be in line with analyst expectations following further "significant" contract wins in the second half. In a post-close trading update, the company said FY25 adjusted operating profit will be in line with market expectations of £75.8m, while adjusted earnings per share are expected to benefit from slightly lower finance costs.
The group's adjusted operating margin is expected to be around 14.7%, versus 14.2% a year earlier, with a stronger-than-expected performance from its energetics division.
"We continue to see increased levels of demand for propellants, energetic materials and high-integrity devices, as customers re-evaluate operational usage and stockpile requirements associated with traditional defence capabilities," the company said.
"This has offset continued softness in Sensors & Information resulting primarily from delayed UK Government order placement across both National Security and Defence areas, which is a continuation of the trend we highlighted in our interim results."
The defence firm also said it was assessing strategic options for Alloy Surfaces, one of its US countermeasures businesses, which will be reported as discontinued in the FY25 results.
At 31 October, the order intake for the year was around £781m, up from £648m at the same time last year, while the order book was around £1.3bn, up from £1bn, as Chemring continues to win "significant" orders.
The company struck an upbeat note on its outlook.
"The group continues to see robust market conditions, with increasing customer demand for its technology-driven solutions and a resurgent demand for traditional defence capabilities," it said. "This strong outlook is expected to be maintained."
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.